HIV-1 Gag protein with or without p6 specifically dimerizes on the viral RNA packaging signal.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
16 10 2020
Historique:
received: 17 06 2020
revised: 10 08 2020
pubmed: 21 8 2020
medline: 24 2 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

The HIV-1 Gag protein is responsible for genomic RNA (gRNA) packaging and immature viral particle assembly. Although the presence of gRNA in virions is required for viral infectivity, in its absence, Gag can assemble around cellular RNAs and form particles resembling gRNA-containing particles. When gRNA is expressed, it is selectively packaged despite the presence of excess host RNA, but how it is selectively packaged is not understood. Specific recognition of a gRNA packaging signal (Psi) has been proposed to stimulate the efficient nucleation of viral assembly. However, the heterogeneity of Gag-RNA interactions renders capturing this transient nucleation complex using traditional structural biology approaches challenging. Here, we used native MS to investigate RNA binding of wild-type (WT) Gag and Gag lacking the p6 domain (GagΔp6). Both proteins bind to Psi RNA primarily as dimers, but to a control RNA primarily as monomers. The dimeric complexes on Psi RNA require an intact dimer interface within Gag. GagΔp6 binds to Psi RNA with high specificity

Identifiants

pubmed: 32817318
pii: S0021-9258(17)49781-X
doi: 10.1074/jbc.RA120.014835
pmc: PMC7573273
doi:

Substances chimiques

RNA, Viral 0
gag Gene Products, Human Immunodeficiency Virus 0
p6 gag protein, Human immunodeficiency virus 1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

14391-14401

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM118291
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM065056
Pays : United States
Organisme : NIAID NIH HHS
ID : U54 AI150472
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI153216
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM128577
Pays : United States

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

J Virol. 2011 May;85(9):4111-21
pubmed: 21325421
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1437-1442
pubmed: 27965093
J Virol. 2015 Dec 04;90(4):1773-87
pubmed: 26637452
Anal Chem. 2015 Apr 21;87(8):4370-6
pubmed: 25799115
Nucleic Acids Res. 1987 Nov 11;15(21):8783-98
pubmed: 3684574
J Virol. 2017 Jul 27;91(16):
pubmed: 28539452
J Phys Chem Lett. 2017 Mar 16;8(6):1105-1112
pubmed: 28207277
PLoS Pathog. 2013 Mar;9(3):e1003249
pubmed: 23555259
Nat Rev Microbiol. 2015 Aug;13(8):484-96
pubmed: 26119571
Nat Methods. 2014 Oct;11(10):1064-70
pubmed: 25173706
J Virol. 2007 Jun;81(12):6623-31
pubmed: 17392359
RNA Biol. 2018;15(7):923-936
pubmed: 29954247
Trends Microbiol. 2019 Aug;27(8):715-723
pubmed: 31085095
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19114-9
pubmed: 19861549
Annu Rev Cell Biol. 1988;4:611-47
pubmed: 3058168
J Mol Biol. 2015 Mar 27;427(6 Pt B):1480-1494
pubmed: 25644662
Science. 1997 Oct 31;278(5339):849-53
pubmed: 9346481
Trends Microbiol. 2013 Mar;21(3):136-44
pubmed: 23266279
Cell. 2014 Nov 20;159(5):1096-1109
pubmed: 25416948
PLoS Pathog. 2010 Nov 18;6(11):e1001200
pubmed: 21124996
Science. 2015 May 22;348(6237):917-21
pubmed: 25999508
Curr Opin Struct Biol. 1999 Apr;9(2):231-43
pubmed: 10322217
Biophys Chem. 1997 Feb 28;64(1-3):139-55
pubmed: 17029833
J Biol Chem. 2019 Nov 8;294(45):16480-16493
pubmed: 31570521
Nucleic Acids Res. 2019 Jan 25;47(2):929-940
pubmed: 30418624
RNA. 2013 Aug;19(8):1078-88
pubmed: 23798665
J Mol Biol. 2011 Jul 22;410(4):609-33
pubmed: 21762803
Biophys J. 2009 Mar 4;96(5):1961-9
pubmed: 19254556
Virology. 2014 Apr;454-455:362-70
pubmed: 24530126
Semin Cell Dev Biol. 2019 Feb;86:129-139
pubmed: 29580971
Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7
pubmed: 2405382
Annu Rev Virol. 2018 Sep 29;5(1):165-183
pubmed: 30048218
J Mol Biol. 1976 Oct 25;107(2):145-58
pubmed: 1003464
Elife. 2018 Aug 02;7:
pubmed: 30070634
J Virol. 2002 Jan;76(1):105-17
pubmed: 11739676
Science. 1998 Jan 16;279(5349):384-8
pubmed: 9430589
Biochemistry. 2008 Feb 19;47(7):2199-210
pubmed: 18225865
J Am Soc Mass Spectrom. 2019 Jan;30(1):118-127
pubmed: 29667162
Methods Mol Biol. 2009;498:297-307
pubmed: 18988033
J Virol. 2014 Mar;88(6):3577-85
pubmed: 24403576
RNA Biol. 2017 Jan 2;14(1):90-103
pubmed: 27841704
J Mol Biol. 2011 Jul 22;410(4):653-66
pubmed: 21762806
J Mol Biol. 1999 Jan 8;285(1):1-32
pubmed: 9878383
PLoS Pathog. 2017 Feb 21;13(2):e1006221
pubmed: 28222188
Virology. 1998 Nov 10;251(1):1-15
pubmed: 9813197
J Mol Biol. 2011 Jul 22;410(4):553-64
pubmed: 21762800
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006924
pubmed: 22762019
Drug Discov Today. 2019 May;24(5):1139-1147
pubmed: 30885676
J Mol Biol. 2011 Feb 18;406(2):205-14
pubmed: 21134384
J Mol Biol. 2014 Apr 3;426(7):1611-24
pubmed: 24316368
Methods Mol Biol. 2015;1259:385-402
pubmed: 25579598
J Mol Biol. 2000 Aug 11;301(2):491-511
pubmed: 10926523
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1600-5
pubmed: 20080620
J Virol. 1997 Jul;71(7):4892-903
pubmed: 9188551
J Mol Biol. 2007 Jan 19;365(3):799-811
pubmed: 17098251
Methods Mol Biol. 2009;485:197-208
pubmed: 19020827
Viruses. 2016 Sep 19;8(9):
pubmed: 27657107
Elife. 2017 Jul 20;6:
pubmed: 28726630
Sci Rep. 2018 Nov 2;8(1):16283
pubmed: 30389967
Nat Commun. 2014 Jul 02;5:4304
pubmed: 24986025
J Virol. 1993 Jul;67(7):4264-73
pubmed: 7685414
J Cell Biol. 2015 Aug 17;210(4):629-46
pubmed: 26283800

Auteurs

Samantha Sarni (S)

Ohio State Biochemistry Program, The Ohio State University, Columbus, Ohio, USA.
Resource for Native Mass Spectrometry Guided Structural Biology, The Ohio State University, Columbus, Ohio, USA.
Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.

Banhi Biswas (B)

HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.

Shuohui Liu (S)

Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.
Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA.

Erik D Olson (ED)

Ohio State Biochemistry Program, The Ohio State University, Columbus, Ohio, USA.
Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.
Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA.

Jonathan P Kitzrow (JP)

Ohio State Biochemistry Program, The Ohio State University, Columbus, Ohio, USA.
Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.
Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA.

Alan Rein (A)

HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.

Vicki H Wysocki (VH)

Ohio State Biochemistry Program, The Ohio State University, Columbus, Ohio, USA musier-forsyth.1@osu.edu wysocki.11@osu.edu.
Resource for Native Mass Spectrometry Guided Structural Biology, The Ohio State University, Columbus, Ohio, USA.
Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.

Karin Musier-Forsyth (K)

Ohio State Biochemistry Program, The Ohio State University, Columbus, Ohio, USA musier-forsyth.1@osu.edu wysocki.11@osu.edu.
Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.
Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH